固形腫瘍薬の世界市場2021

◆英語タイトル:Global Solid Tumors Drug Market Research Report 2021
◆商品コード:QYR60904476
◆発行会社(リサーチ会社):QYResearch
◆発行日:2016年7月13日
◆ページ数:125
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single UserUSD2,900 ⇒換算¥324,800見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD5,800 ⇒換算¥649,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、固形腫瘍薬の世界市場について調査・分析し、市場概観、市場動向、固形腫瘍薬の世界市場規模、市場予測、地域別市場規模(日本市場、中国市場、米国市場、欧州市場など)、種類別市場分析、用途別市場分析、主要なメーカー分析(企業概要、主な製品概要、生産・販売動向、連絡先など)、市場シェア分析などを含め、以下の構成でお届けいたします。

・固形腫瘍薬の世界市場:市場概要
・固形腫瘍薬の世界市場:市場動向
・固形腫瘍薬の世界市場:市場規模、市場規模予測
・固形腫瘍薬の地域別市場規模(日本市場、中国市場、アメリカ市場、ヨーロッパ市場など)
・固形腫瘍薬の世界市場:種類別市場分析
・固形腫瘍薬の世界市場:用途別市場分析
・固形腫瘍薬の企業間競争状況
・固形腫瘍薬の主要なメーカー分析(企業情報、主な製品概要、生産・販売動向、連絡先など)
・固形腫瘍薬の世界市場:産業政策動向分析
・固形腫瘍薬の世界市場:市場シェア分析
・固形腫瘍薬の世界市場:結論
...
【レポートの概要】

This report studies Solid Tumors Drug in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering F. Hoffmann-La Roche
Novartis
Celgene
Johnson & Johnson
Pfizer
BMS
Bayer
AbbVie
Boston Biomedical
Eli Lilly
GSK
Merck
Novartis
Sanofi
Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Solid Tumors Drug in these regions, from 2011 to 2021 (forecast), like
North America
China
Europe
Japan
India
Southeast Asia
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type 1
Type 2
Type 3
Split by application, this report focuses on sales, market share and growth rate of Solid Tumors Drug in each application, can be divided into
Application 1
Application 2
Application 3

【レポートの目次】

Table of Contents

Global Solid Tumors Drug Market Research Report 2021
1 Solid Tumors Drug Overview
1.1 Product Overview and Scope of Solid Tumors Drug
1.2 Solid Tumors Drug Segment by Types
1.2.1 Global Sales Market Share of Solid Tumors Drug by Type in 2015
1.2.2 Type 1
1.2.3 Type 2
1.2.4 Type 3
1.3 Solid Tumors Drug Segment by Applications
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Solid Tumors Drug Market by Regions
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Solid Tumors Drug (2011-2021)
1.5.1 Global Solid Tumors Drug Sales and Revenue (2011-2021)
1.5.2 Global Solid Tumors Drug Sales and Growth Rate (2011-2021)
1.5.3 Global Solid Tumors Drug Revenue and Growth Rate (2011-2021)

2 Global Solid Tumors Drug Market Competition by Manufacturers
2.1 Global Solid Tumors Drug Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Solid Tumors Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Solid Tumors Drug Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
2.4.1 Expansions
2.4.2 New Product Launches
2.4.3 Acquisitions
2.4.4 Other Developments

3 Global Solid Tumors Drug Analysis by Region
3.1 Global Solid Tumors Drug Sales, Revenue and Market Share by Region (2011-2021)
3.1.1 Global Solid Tumors Drug Sales Market Share by Region (2011-2021)
3.1.2 Global Solid Tumors Drug Revenue Market Share by Region (2011-2021)
3.2 North America
3.2.1 North America Solid Tumors Drug Sales, Revenue and Price (2011-2021)
3.2.2 North America Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
3.3.1 Europe Solid Tumors Drug Sales, Revenue and Price (2011-2021)
3.3.2 Europe Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
3.4 China
3.4.1 China Solid Tumors Drug Sales, Revenue and Price (2011-2021)
3.4.2 China Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
3.5.1 Japan Solid Tumors Drug Sales, Revenue and Price (2011-2021)
3.5.2 Japan Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
3.6 India
3.6.1 India Solid Tumors Drug Sales, Revenue and Price (2011-2021)
3.6.2 India Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
3.7.1 Southeast Asia Solid Tumors Drug Sales, Revenue and Price (2011-2021)
3.7.2 Southeast Asia Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)

4 Global Solid Tumors Drug Analysis by Type
4.1 Global Solid Tumors Drug Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
4.1.1 Global Solid Tumors Drug Sales and Market Share by Type (2011-2021)
4.1.2 Global Solid Tumors Drug Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Type 1 Sales, Revenue, Price and Growth (2011-2020)
4.3 Type 2 Sales, Revenue, Price and Growth (2011-2020)
4.4 Type 3 Sales, Revenue, Price and Growth (2011-2020)

5 Global Solid Tumors Drug Market Analysis by Application
5.1 Global Solid Tumors Drug Sales and Market Share by Application (2011-2021)
5.2 Major Regions Solid Tumors Drug Sales by Application in 2015 and 2016
5.2.1 North America Solid Tumors Drug Sales by Application
5.2.2 Europe Solid Tumors Drug Sales by Application
5.2.3 China Solid Tumors Drug Sales by Application
5.2.4 Japan Solid Tumors Drug Sales by Application
5.2.5 India Solid Tumors Drug Sales by Application
5.2.6 Southeast Asia Solid Tumors Drug Sales by Application

6 Global Solid Tumors Drug Manufacturers Analysis
6.1 F. Hoffmann-La Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Solid Tumors Drug Product Overview
6.1.2.1 Type 1
6.1.2.2 Type 2
6.1.2.3 Type 3
6.1.3 Solid Tumors Drug Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)
6.2 Novartis
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Solid Tumors Drug Product Overview
6.2.2.1 Type 1
6.2.2.2 Type 2
6.2.2.3 Type 3
6.2.3 Solid Tumors Drug Sales, Revenue, Price of Novartis (2015 and 2016)
6.3 Celgene
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Solid Tumors Drug Product Overview
6.3.2.1 Type 1
6.3.2.2 Type 2
6.3.2.3 Type 3
6.3.3 Solid Tumors Drug Sales, Revenue, Price of Celgene (2015 and 2016)
6.4 Johnson & Johnson
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Solid Tumors Drug Product Overview
6.4.2.1 Type 1
6.4.2.2 Type 2
6.4.3 Solid Tumors Drug Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
6.5 Pfizer
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Solid Tumors Drug Product Overview
6.5.2.1 Type 1
6.5.2.2 Type 2
6.5.3 Solid Tumors Drug Sales, Revenue, Price of Pfizer (2015 and 2016)
6.6 BMS
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Solid Tumors Drug Product Overview
6.6.2.1 Type 1
6.6.2.2 Type 2
6.6.3 Solid Tumors Drug Sales, Revenue, Price of BMS (2015 and 2016)
6.7 Bayer
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Solid Tumors Drug Product Overview
6.7.2.1 Type 1
6.7.2.2 Type 2
6.7.3 Solid Tumors Drug Sales, Revenue, Price of Bayer (2015 and 2016)
6.8 AbbVie
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Solid Tumors Drug Product Overview
6.8.2.1 Type 1
6.8.2.2 Type 2
6.8.3 Solid Tumors Drug Sales, Revenue, Price of AbbVie (2015 and 2016)
6.9 Boston Biomedical
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Solid Tumors Drug Product Overview
6.9.2.1 Type 1
6.9.2.2 Type 2
6.9.3 Solid Tumors Drug Sales, Revenue, Price of Boston Biomedical (2015 and 2016)
6.10 Eli Lilly
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Solid Tumors Drug Product Overview
6.10.2.1 Type 1
6.10.2.2 Type 2
6.10.3 Solid Tumors Drug Sales, Revenue, Price of Eli Lilly (2015 and 2016)
6.11 GSK
6.12 Merck
6.13 Novartis
6.14 Sanofi

7 Industry Policy Analysis

8 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Solid Tumors Drug
Figure Global Sales Market Share of Solid Tumors Drug by Type in 2015
Table Solid Tumors Drug Product Type of by Manufacturers
Table Solid Tumors Drug Sales Market Share by Application in 2015 and 2016
Figure North America Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Figure China Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Figure Europe Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Figure Japan Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Figure India Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Table Global Solid Tumors Drug Sales and Revenue (2011-2021)
Figure Global Solid Tumors Drug Sales and Growth Rate (2011-2021)
Figure Global Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Table Global Solid Tumors Drug Sales of Key Manufacturers (2015 and 2016)
Table Global Solid Tumors Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Solid Tumors Drug Sales Share by Manufacturers
Figure 2016 Solid Tumors Drug Sales Share by Manufacturers
Table Global Solid Tumors Drug Revenue by Manufacturers (2015 and 2016)
Table Global Solid Tumors Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Solid Tumors Drug Revenue Share by Manufacturers
Table 2016 Global Solid Tumors Drug Revenue Share by Manufacturers
Table Manufacturers Solid Tumors Drug Manufacturing Base Distribution and Product Type
Table Global Solid Tumors Drug Sales Market by Region (2011-2021)
Figure Global Solid Tumors Drug Sales Market by Region (2011-2021)
Figure Global Solid Tumors Drug Sales Market Share by Region (2011-2021)
Table Global Solid Tumors Drug Revenue Market by Region (2011-2021)
Table Global Solid Tumors Drug Revenue Market Share by Region (2011-2021)
Table North America Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure North America Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
Table Europe Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure Europe Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
Table China Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure China Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
Table Japan Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure Japan Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
Table India Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure India Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
Table Global Solid Tumors Drug Sales by Type (2011-2021)
Table Global Solid Tumors Drug Sales Share by Type (2011-2021)
Figure Sales Market Share of Solid Tumors Drug by Type (2011-2021)
Figure Global Solid Tumors Drug Sales Growth Rate by Type (2011-2021)
Table Global Solid Tumors Drug Revenue by Type (2011-2021)
Table Global Solid Tumors Drug Revenue Share by Type (2011-2021)
Figure Global Solid Tumors Drug Revenue Growth Rate by Type (2011-2021)
Figure Type 1 Sales, Revenue and Growth (2011-2021)
Figure Type 1 Price Trend (2011-2021)
Figure Type 2 Sales, Revenue and Growth (2011-2021)
Figure Type 2 Price Trend (2011-2021)
Figure Type 3 Sales, Revenue and Growth (2011-2021)
Figure Type 3 Price Trend (2011-2021)
Table Global Solid Tumors Drug Sales by Application (2011-2021)
Table Global Solid Tumors Drug Sales Market Share by Application (2011-2021)
Figure Global Solid Tumors Drug Sales Market Share by Application in 2015
Figure Global Solid Tumors Drug Sales Market Share by Application in 2021
Table North America Solid Tumors Drug Sales by Application (2015 and 2016)
Table Europe Solid Tumors Drug Sales by Application (2015 and 2016)
Table China Solid Tumors Drug Sales by Application (2015 and 2016)
Table Japan Solid Tumors Drug Sales by Application (2015 and 2016)
Table India Solid Tumors Drug Sales by Application (2015 and 2016)
Table Southeast Asia Solid Tumors Drug Sales by Application (2015 and 2016)
Table Global Solid Tumors Drug Sales Growth Rate by Application (2011-2021)
Figure Global Solid Tumors Drug Sales Growth Rate by Application (2011-2021)
Table F. Hoffmann-La Roche Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)
Table Novartis Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Novartis (2015 and 2016)
Table Celgene Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Celgene (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table Pfizer Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Pfizer (2015 and 2016)
Table BMS Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of BMS (2015 and 2016)
Table Bayer Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Bayer (2015 and 2016)
Table AbbVie Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of AbbVie (2015 and 2016)
Table Boston Biomedical Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Boston Biomedical (2015 and 2016)
Table Eli Lilly Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Eli Lilly (2015 and 2016)
Table GSK Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of GSK (2015 and 2016)
Table Merck Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Merck (2015 and 2016)
Table Novartis Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Novartis (2015 and 2016)
Table Sanofi Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Sanofi (2015 and 2016)


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 固形腫瘍薬の世界市場2021(Global Solid Tumors Drug Market Research Report 2021)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆